ArticleBritish journal of clinical pharmacology2022

Pre-approval and post-approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs.

Lourens T Bloem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.